4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001741533-26-000002
CHIEF MEDICAL OFFICER sold 40,000 shares at an average $44.82 ($1,792,940)
- CHIEF MEDICAL OFFICER acquired 40,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Paolini John F. · CHIEF MEDICAL OFFICER
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +40,000 | $10.36 | $414,400 | 101,324 | D |
| 2026-03-02 | Sale : show line 2 in the form 10b5-1 | −12,063 | $44.20 | $533,185 | 89,261 | D |
| 2026-03-02 | Sale : show line 3 in the form 10b5-1 | −22,223 | $44.88 | $997,368 | 67,038 | D |
| 2026-03-02 | Sale : show line 4 in the form 10b5-1 | −5,714 | $45.92 | $262,387 | 61,324 | D |
| Open-market sales · 40,000 sh · avg $44.82 · $1,792,940 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-02 | Exercise or conversion : show line 5 in the form 10b5-1 Share Option | −40,000 | 58,424 | D |
Loading xslF345X05/form4-03042026_090352.xml…